quantum-dots-xray-image

Scientists at the Sanford Burnham Prebys Medical Discovery Institute (SBP) in San Diego, California have devised a way to optically image tumors with unprecedented clarity using quantum dots. These nano structures are tiny particles, only a few nanometers wide, that generate light of a specific wavelength when they’re themselves stimulated by a light beam. On their own quantum dots are quite bright, but their signal gets washed out by other nearby quantum dots. To clean the signal and be able to see tumors better, the SBP team used a so-called “etchant”.

kim-mickey-inova-image

Inova announced today that Mickey Y. Kim, MD, MBA, has been named Senior Vice President of Research and Commercialization. In this role, Dr. Kim will work with Inova's institute leaders to establish Inova's research priorities, manage its portfolio, work collaboratively with Inova's external partners, and drive the commercialization of research.

fda-logo

Do you have experience in digital health? Are you passionate about developing innovative solutions to complex challenges? If so, consider joining the FDA Digital Health team as an Entrepreneur-in-Residence! The Center for Devices and Radiological Health (CDRH) is establishing this Entrepreneur-in-Residence (EIR) Program to support and help develop our Software Precertification (PreCert) Pilot Program —a critical piece of our Digital Health Innovation Action Plan, announced on August 8, 2017.

mcedc-openhous-2017-image

DATE AND TIME: Wed, September 27, 2017 8:00 AM – 10:00 AM EDT

LOCATION: 1801 Rockville Pike Suite 320 Rockville, MD 20852

Join us for our open house to connect and network in our new Rockville offices. Enjoy breakfast and discover the many services we offer to help expand business opportunities in MoCo.

We hope you can join us.

Garage parking is available in the building. If you have any questions, please contact Meaghann Diez at This email address is being protected from spambots. You need JavaScript enabled to view it..

stem-cells-pixa

The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $115,000 grant to further develop and commercialize a multi-specific antibody as a therapeutic for HIV.  The grant is funded under the Maryland Innovation Initiative (MII) by the Maryland Technology Development Corporation (TEDCO) that supports the commercialization of academic-based research in the State of Maryland and thereby supports the State’s efforts to foster economic development.  The MII program is a collaboration between the State of Maryland and five Maryland Institutions:  University of Maryland, Baltimore, University of Maryland, College Park, Morgan State University, University of Maryland Baltimore County, and Johns Hopkins University.

bio-trac-090717-logo

Wednesday, October 18 – Friday, October 20, 2017 at the MC Bioscience Education Center in Germantown, MD.

Bio-Trac® Training Programs is currently accepting preregistrations for our 2017 hands-on training workshops. Preregistration is strongly encouraged due to our small class sizes. Simply provide the few required details below and indicate applicable course(s).  We will contact you directly with complete details upon receipt of your preregistration.

mdbio-verizon-bus-image

MdBio Foundation is excited to be partnering with Verizon Innovative Learning to bring a new mobile experience to District of Columbia Public Schools. The Verizon Innovative Learning explorer lab is an entirely new way for middle school students to discover concepts of engineering design. The explorer lab is a shared immersive learning experience that combines movie-quality video, special effects, and hands-on educational gaming to create a learning environment that gets kids excited about science, technology, engineering and math (STEM) – right in the school parking lot.

5th-pediatric-device-logo

Join us on September 24, 2017 in San Jose, CA, one day before The MedTech Conference powered by AdvaMed, for the 5th Annual Pediatric Device Innovation Symposium. This year’s theme is “Partnering for Breakthroughs in Pediatric Surgery and Care.”

TOP REASONS TO ATTEND

  1. Network and form new partnerships in the world of pediatric device innovation
  2. Get inspired by Daniel Kraft, MD as he discusses the future of health and medicine
  3. Learn from Alan Flake, MD about the promise of the “Artificial Womb” device that could help babies born extremely prematurely
  4. Hear Vasum Peiris, MD of the FDA talk about hot healthcare issues affecting children
  5. Engage and be an active participant during Hot-Button panel discussions that will cover topics from funding to regulations to market dynamics – as they relate to the health of our children

bio-buzz-23-logo

When: Thursday, September 14, 2017 from 5:00 PM to 7:00 PM EDT

Where: BIOTrain @ Montgomery College Germantown 20200 Observation Drive Germantown, MD 20876

Join BioBuzz and sponsor BIOTrain for our next networking event and showcase of the continuing-education and workforce support programs throughout the county and state.

There also will be a tour of Montgomery College's state-of-the-art labs in the same building around 6pm.

childrens-national-health-gwu-logo

The National Center for Advancing Translational Sciences at the National Institutes of Health has awarded Children’s National Health System, in partnership with The George Washington University (GW), another prestigious Clinical and Translational Science Award. The grant, made available to facilities across the nation through a competitive process, underwrites the existing Clinical and Translational Science Institute at Children’s National (CTSI-CN) and provides funding that is essential to continue the collaborative pediatric-focused translational research occurring at Children’s and at GW. 

ncet2-logo

Experienced Startup Development Officers Help Universities, Faculty, Researchers, Students and Entrepreneurs Create, Develop and Fund University Startups and IP

Join this webinar to learn more about: How to Attract Venture Capital Wednesday, September 6, 1:00 pm ET/10:00 am PT

WHO SHOULD ATTEND: Researchers, Students, Faculty, Entrepreneurs, Startups, Vice Presidents of Research, University Tech Transfer Offices, Open Innovation Officers, Chief Innovation Officers, Angel Groups, VCs, University Venture Funds, University Angel Groups

Nanochon-gw-image

In July 2017, Nanochon LLC and CEO Ben Holmes were awarded a Phase I SBIR grant from the National Science Foundation. The grant will fund the development of an implantable medical device for cartilage repair in the knee, based on 3D printing technology. Nanochon LLC was founded by Ben Holmes and Nathan Castro and is based on their work in Grace Zhang's Tissue Engineering Lab.

fda-logo

On May 11, Scott Gottlieb, M.D., officially became the 23rd commissioner of the U.S. Food and Drug Administration (FDA). Dr. Gottlieb has previous FDA experience, having served as deputy commissioner for medical and scientific affairs, among other positions, during the George W. Bush administration. More recently, he was a venture partner at the world’s largest venture capitalist firm, New Enterprise Associates (NEA), sitting on the boards of several pharmaceutical companies, including GSK, Daiichi Sankyo, and Vertex. He was also a clinical assistant professor and practiced medicine at the New York University (NYU) School of Medicine, and is a cancer survivor (Hodgkin’s lymphoma).

MOCO365-tami-howie-image

Maryland Tech Council CEO, Tami Howie talks with Montgomery County Economic Development Corporation for #MOCO365 on educating, advocating and connecting biotech and tech companies in Maryland.

sharevault-logo

September 28, 2017 11a PT/ 2p ET

Join us for a web panel discussion on how to successfully move a life science organization from founding to exit. During this discussion, founders will provide guidance on how executive teams can partner business and science together to overcome the stumbling blocks along the way and achieve results.  Learn what is real and what is myth!

BHCR logo 500

This summer in the Genetic Engineering & Biotechnology News Annual Rankings of the "Top 10 U.S. Biopharma Clusters", the BioHealth Capital Region (BHCR) moved up to #5. NIH funding, Venture Capital funding, Patents, Lab Space, and Jobs all are factored into the BHCR's move into the Top-5.

"Area biopharma leaders have committed to growing their “BioHealth Capital Region” cluster into one of the nation’s top three by 2023, building on anchors ranging from the NIH and FDA, to the nation’s top academic recipient of research grant funding, the Johns Hopkins University. Hopkins accounts for 64.5% of the region’s NIH funding (556 awards totaling $271.4 million), placing fourth with 880 awards totaling nearly $420.7 million. The region is close to meeting its goal in patents (fourth with 4,108), but further back in employment (eighth with 39,145 jobs, according to JLL) and lab space (sixth with 9.5 million square feet).

Vaccine developers continue to grow: In May, Gaithersburg-based Emergent BioSciences opened an $80 million expanded medical countermeasures plant in East Baltimore, while GlaxoSmithKline announced a $139 million capacity expansion at its API plant in Rockville, MD, due to growing demand for its lupus erythematosus treatment Benlysta® (belimumab). The region finished sixth in VC funding last year ($146 million), but climbed to fourth during Q1 (seven awards totaling $71 million). Courting the industry eagerly are both Virginia Gov. Terry McAuliffe (D) and Maryland Gov. Larry Hogan (R), a non-Hodgkin's lymphoma survivor who calls the cluster-building effort a personal mission."

Click here to read the entire article via Gen

funding-money-invest-pixa

Corporate venture firms are a well-established presence on the biotech funding scene, with the likes of Novartis and Glaxosmithkine’s SR One among the most active investors in the sector. However, the past few years have seen some different names crop up more and more: Pfizer, Celgene and Roche have noticeably stepped up their financing activity, a new analysis by EP Vantage finds.

nhlbi-nih-logo

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices

  • Notice of Participation of National Institute of Allergy and Infectious Diseases (NIAID) on RFA-CA-17-031 " Limited Competition: A Data Resource for Analyzing Blood and Marrow Transplants (U24) 
    • (NOT-AI-17-038)
    • National Institute of Allergy and Infectious Diseases
  • Notice of Applicant Information Webinar for the Point-of-Care Technologies Research Network Centers (U54)
    • (NOT-EB-17-010)
    • National Institute of Biomedical Imaging and Bioengineering
  • Notice of Intent to Publish: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38)
  • Notice Announcing an Applicant Information Webinar for Phase II of the Undiagnosed Diseases Network (RFA-RM-17-019, RFA-RM-17-018, RFA-RM-17-017, RFA-RM-17-016, RFA-RM-17-015)"

Requests for Applications

  • Stimulating Access to Research in Residency (StARR) (R38)

Program Announcements

  • Continuation of Existing Grant Based Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01)
    • (PAR-17-338
    • National Heart, Lung, and Blood Institute
  • Clinical and Epidemiological Research on Chronic Disease in the Caribbean (R01)
    • (PAR-17-470
    • National Heart, Lung, and Blood Institute
meda-logo

The MOVE program is an innovative approach intended to attract new businesses to Montgomery County, Maryland. Eligible new businesses will receive a one-time grant upon signing a commercial lease within the county.

Businesses new to the county that lease up to 20,000 square feet of Class A or B office space may receive a grant of $8/sf. All grants are capped at 10,000 square feet for purposes of calculating the grant award.